Tag: Neurology and Neuroscience
-
New Spherical Nucleic Acid ‘Drug’ Kills Tumor Cells in Humans With Glioblastoma
An experimental spherical nucleic acid drug developed by Northwestern scientists was able to penetrate the blood-brain barrier and trigger the death of glioblastoma cells.
-
New Genetic Cause of Dystonia Revealed
Northwestern Medicine scientists discovered mutations in a scaffolding protein contributes to dystonia, an incurable movement disorder.
-
Blocking Cell Division in Glioblastoma
Blocking the arginine methylation pathway, which helps brain tumor cells proliferate by promoting cell division, could improve cancer therapies, according to a recent study.
-
Untangling Cellular Changes in Pediatric Epilepsy
For the first time, Northwestern Medicine scientists have characterized how a genetic mutation associated with pediatric epilepsy affects neuron activity.
-
Plotting the Neural Circuitry of Appetite Suppression
Northwestern Medicine scientists have uncovered a neural circuit that drives fear-induced suppression of feeding, according to a study published in Neuron.
-
‘Logic Circuit’ in Cochlear Neurodevelopment Identified
For the first time, Northwestern Medicine scientists have uncovered the complex logic that determines how cochlear cells are connected to the brain during neurodevelopment, according to a recent study.
-
New Therapeutic Prospect for ALS
An experimental drug called ezogabine reduced spinal neuron excitability in patients with ALS, according to a recent study.
-
Protein Regulation Network May Influence Psychiatric Disorders
Homer1, a protein that’s important for neural plasticity and learning, is part of a large network of proteins in the brain that help ensure new connections are wired correctly, according to a new study.
-
New Developments in Parkinson’s Pathology
The strength of neuron-to-neuron connections does not govern the spread of Parkinson’s disease in the brain, according to a recent study.
-
Medical Students Discuss Study Showing Neurological Impact of COVID-19
Second-year medical students Jeff Clark, Nathan Shlobin, and Steven Hoffman are the co-authors of a first of its kind study, which found that more than 80 percent of patients hospitalized with COVID-19 experienced neurological manifestations.
